Amneal Pharmaceuticals, Inc. AMRX Intellectual property legal development expenses
Intellectual property legal development expenses at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept amrx:IntellectualPropertyLegalDevelopmentExpenses.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s intellectual property legal development expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s intellectual property legal development expenses?
- Amneal Pharmaceuticals, Inc. (AMRX) reported intellectual property legal development expenses of $1.54M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s intellectual property legal development expenses changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s intellectual property legal development expenses decreased by 12.7% year-over-year, from $1.77M to $1.54M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s intellectual property legal development expenses?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s intellectual property legal development expenses has grown at a 20.5% compound annual growth rate (CAGR), from $4.36M to $7.63M.
- What does intellectual property legal development expenses mean?
- This metric represents the costs incurred by the company related to the legal protection, defense, and development of its intellectual property portfolio. It captures expenditures associated with patent filings, litigation to enforce proprietary rights, and legal strategies aimed at securing market exclusivity for pharmaceutical products. Monitoring these costs helps investors assess the company's investment in maintaining its competitive moat and the legal risks associated with its product pipeline.